ADAR1 Capital Management LLC acquired a new stake in Alpha Cognition, Inc. (NASDAQ:ACOG - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 204,348 shares of the company's stock, valued at approximately $1,204,000. ADAR1 Capital Management LLC owned 1.28% of Alpha Cognition at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Rosalind Advisors Inc. purchased a new position in shares of Alpha Cognition during the 4th quarter worth approximately $1,489,000. Aristides Capital LLC acquired a new position in Alpha Cognition during the fourth quarter worth $1,178,000. Finally, National Bank of Canada FI purchased a new position in shares of Alpha Cognition during the fourth quarter worth $69,000.
Alpha Cognition Trading Up 5.0 %
Shares of Alpha Cognition stock traded up $0.21 during trading hours on Friday, reaching $4.38. 63,121 shares of the company were exchanged, compared to its average volume of 82,208. The company has a market capitalization of $70.17 million, a price-to-earnings ratio of -1.71 and a beta of 2.50. Alpha Cognition, Inc. has a 1 year low of $3.75 and a 1 year high of $7.00. The firm has a fifty day moving average of $5.45.
Alpha Cognition (NASDAQ:ACOG - Get Free Report) last released its earnings results on Monday, March 31st. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.48) by ($0.03).
Wall Street Analyst Weigh In
ACOG has been the topic of several research reports. HC Wainwright reissued a "buy" rating and set a $20.00 target price on shares of Alpha Cognition in a research note on Monday, March 31st. Raymond James raised shares of Alpha Cognition to a "moderate buy" rating in a research note on Tuesday, March 25th.
Read Our Latest Analysis on ACOG
Alpha Cognition Profile
(
Free Report)
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
See Also
Before you consider Alpha Cognition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Cognition wasn't on the list.
While Alpha Cognition currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
